• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在纤维蛋白存在的情况下,链激酶与改良形式的纤溶酶原(赖氨酸-纤溶酶原)混合物的激活剂活性增强:纤溶酶原构象变化的作用

Enhanced activator activity of the mixture of streptokinase and a modified form of plasminogen (Lys-plasminogen) in the presence of fibrin: role of conformational change of plasminogen.

作者信息

Takada A, Takada Y, Sugawara Y

机构信息

Department of Physiology, Hamamatsu University, School of Medicine, Shizuoka, Japan.

出版信息

Haemostasis. 1988;18(2):106-12. doi: 10.1159/000215790.

DOI:10.1159/000215790
PMID:3410360
Abstract

Equimolar concentrations of Lys-plasminogen (Lys-PLG) and streptokinase (SK) were mixed with various concentrations of fibrin, fibrinogen, fragment D or E (potentiating agents). The activity of the mixture was measured by the hydrolysis of S-2251. Kinetic analyses indicated that catalytic rate constant (kcat) of the hydrolysis of S-2251 increased in the presence of increasing amounts of potentiating agents. Km did not change in their presence. Effectiveness of the enhancement of the hydrolysis of S-2251 was in the order of fibrin greater than fibrinogen greater than E greater than D. It could be concluded that a complex of SK, Lys-PLG and potentiating agent is a better enzyme, thus activator, than a complex of SK and Lys-PLG. Since Lys-PLG does not change its conformation and its activation rate upon interaction with fibrin, the enhanced activator activity of complex of SK, Lys-PLG and potentiating agent may not be due to the conformational change of Lys-PLG.

摘要

将等摩尔浓度的赖氨酸纤溶酶原(Lys-PLG)和链激酶(SK)与不同浓度的纤维蛋白、纤维蛋白原、D片段或E片段(增强剂)混合。通过S-2251的水解来测定混合物的活性。动力学分析表明,在存在越来越多增强剂的情况下,S-2251水解的催化速率常数(kcat)增加。Km在它们存在时没有变化。增强S-2251水解的有效性顺序为纤维蛋白大于纤维蛋白原大于E大于D。可以得出结论,SK、Lys-PLG和增强剂的复合物是比SK和Lys-PLG的复合物更好的酶,因此是激活剂。由于Lys-PLG在与纤维蛋白相互作用时不会改变其构象和激活速率,SK、Lys-PLG和增强剂复合物增强的激活剂活性可能不是由于Lys-PLG的构象变化。

相似文献

1
Enhanced activator activity of the mixture of streptokinase and a modified form of plasminogen (Lys-plasminogen) in the presence of fibrin: role of conformational change of plasminogen.在纤维蛋白存在的情况下,链激酶与改良形式的纤溶酶原(赖氨酸-纤溶酶原)混合物的激活剂活性增强:纤溶酶原构象变化的作用
Haemostasis. 1988;18(2):106-12. doi: 10.1159/000215790.
2
The activation of Glu- and Lys-plasminogens by streptokinase: effects of fibrin, fibrinogen and their degradation products.链激酶对谷氨酸纤溶酶原和赖氨酸纤溶酶原的激活作用:纤维蛋白、纤维蛋白原及其降解产物的影响。
Thromb Res. 1985 Feb 1;37(3):465-75. doi: 10.1016/0049-3848(85)90075-1.
3
Kinetic analyses of potentiation of plasminogen activation by streptokinase in the presence of fibrin or its degradation products.在存在纤维蛋白或其降解产物的情况下,链激酶对纤溶酶原激活的增强作用的动力学分析。
Haemostasis. 1987;17(1-2):1-7. doi: 10.1159/000215552.
4
Activation of Val442-plasminogen (mini-plasminogen) by urokinase, streptokinase and tissue plasminogen activator.尿激酶、链激酶和组织型纤溶酶原激活剂对Val442-纤溶酶原(微型纤溶酶原)的激活作用。
Thromb Res. 1988 Jan 15;49(2):253-63. doi: 10.1016/0049-3848(88)90218-6.
5
Effects of fibrinogen and fibrin on the activation of Glu- and Lys-plasminogen by urokinase.纤维蛋白原和纤维蛋白对尿激酶激活谷氨酸型和赖氨酸型纤溶酶原的影响。
Thromb Res. 1984 Mar 15;33(6):561-9. doi: 10.1016/0049-3848(84)90111-7.
6
Potentiation of the activation of Glu-plasminogen by streptokinase and urokinase in the presence of fibrinogen degradation products.
Thromb Res. 1982 Feb 1;25(3):229-35. doi: 10.1016/0049-3848(82)90242-0.
7
Kinetic analyses of the activation of Glu-plasminogen by urokinase in the presence of fibrin, fibrinogen or its degradation products.在存在纤维蛋白、纤维蛋白原或其降解产物的情况下,尿激酶对谷氨酸纤溶酶原激活作用的动力学分析。
Thromb Res. 1987 Apr 1;46(1):9-18. doi: 10.1016/0049-3848(87)90202-7.
8
Glu-plasminogen I and II: their activation by urokinase and streptokinase in the presence of fibrin and fibrinogen.谷氨酸纤溶酶原I和II:它们在纤维蛋白和纤维蛋白原存在的情况下被尿激酶和链激酶激活。
Thromb Res. 1985 Aug 1;39(3):289-96. doi: 10.1016/0049-3848(85)90224-5.
9
The conversion of streptokinase-plasminogen complex to SK-plasmin complex in the presence of fibrin or fibrinogen.在纤维蛋白或纤维蛋白原存在的情况下,链激酶 - 纤溶酶原复合物向链激酶 - 纤溶酶复合物的转化。
Thromb Res. 1989 Apr 15;54(2):133-9. doi: 10.1016/0049-3848(89)90043-1.
10
[Streptokinase and Staphylokinase: Differences in the Kinetics and Mechanism of Their Interaction with Plasminogen, Inhibitors and Fibrin].[链激酶和葡萄球菌激酶:它们与纤溶酶原、抑制剂及纤维蛋白相互作用的动力学和机制差异]
Bioorg Khim. 2015 Sep-Oct;41(5):565-78. doi: 10.1134/s1068162015050039.